TY - JOUR
T1 - Use of machine learning to predict medication adherence in individuals at risk for atherosclerotic cardiovascular disease
AU - Mirzadeh, Seyed Iman
AU - Arefeen, Asiful
AU - Ardo, Jessica
AU - Fallahzadeh, Ramin
AU - Minor, Bryan
AU - Lee, Jung Ah
AU - Hildebrand, Janett A.
AU - Cook, Diane
AU - Ghasemzadeh, Hassan
AU - Evangelista, Lorraine S.
N1 - Funding Information:
This work was supported in part by the National Institute of Health under grant 1R21NR015410-01 . However, any opinions, findings, conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations.
Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - Background: Medication nonadherence is a critical problem with severe implications in indi-viduals at risk for atherosclerotic cardiovascular disease. Many studies have attempted to predict medication adherence in this population, but few, if any, have been effective in prediction, sug-gesting that essential risk factors remain unidentified. Objective: This study's objective was to (1) establish an accurate prediction model of medi-cation adherence in individuals at risk for atherosclerotic cardiovascular disease and (2) identify significant contributing factors to the predictive accuracy of medication adherence. In particular, we aimed to use only the baseline questionnaire data to assess medication adherence prediction feasibility. Methods: A sample of 40 individuals at risk for atherosclerotic cardiovascular disease was recruited for an eight-week feasibility study. After collecting baseline data, we recorded data from a pillbox that sent events to a cloud-based server. Health measures and medication use events were analyzed using machine learning algorithms to identify variables that best predict medication adherence. Results: Our adherence prediction model, based on only the ten most relevant variables, achieved an average error rate of 12.9%. Medication adherence was closely correlated with being encouraged to play an active role in their treatment, having confidence about what to do in an emergency, knowledge about their medications, and having a special person in their life. Conclusions: Our results showed the significance of clinical and psychosocial factors for pre-dicting medication adherence in people at risk for atherosclerotic cardiovascular diseases. Clini-cians and researchers can use these factors to stratify individuals to make evidence-based decisions to reduce the risks.
AB - Background: Medication nonadherence is a critical problem with severe implications in indi-viduals at risk for atherosclerotic cardiovascular disease. Many studies have attempted to predict medication adherence in this population, but few, if any, have been effective in prediction, sug-gesting that essential risk factors remain unidentified. Objective: This study's objective was to (1) establish an accurate prediction model of medi-cation adherence in individuals at risk for atherosclerotic cardiovascular disease and (2) identify significant contributing factors to the predictive accuracy of medication adherence. In particular, we aimed to use only the baseline questionnaire data to assess medication adherence prediction feasibility. Methods: A sample of 40 individuals at risk for atherosclerotic cardiovascular disease was recruited for an eight-week feasibility study. After collecting baseline data, we recorded data from a pillbox that sent events to a cloud-based server. Health measures and medication use events were analyzed using machine learning algorithms to identify variables that best predict medication adherence. Results: Our adherence prediction model, based on only the ten most relevant variables, achieved an average error rate of 12.9%. Medication adherence was closely correlated with being encouraged to play an active role in their treatment, having confidence about what to do in an emergency, knowledge about their medications, and having a special person in their life. Conclusions: Our results showed the significance of clinical and psychosocial factors for pre-dicting medication adherence in people at risk for atherosclerotic cardiovascular diseases. Clini-cians and researchers can use these factors to stratify individuals to make evidence-based decisions to reduce the risks.
KW - Medication adherence machine learning cardiovascular diseases cloud computing
KW - Surveys and questionnaires
UR - http://www.scopus.com/inward/record.url?scp=85139325866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139325866&partnerID=8YFLogxK
U2 - 10.1016/j.smhl.2022.100328
DO - 10.1016/j.smhl.2022.100328
M3 - Article
AN - SCOPUS:85139325866
SN - 2352-6483
VL - 26
JO - Smart Health
JF - Smart Health
M1 - 100328
ER -